Helicobacter Pylori Antibiotic Susceptibility Testing of Korea

Lymphoma Clinical Trial

Official title: Helicobacter Pylori Antibiotic Susceptibility Testing of Korea

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to make nationwide registry for antimicrobial resistance of Helicobacter pylori using single method with agar dilution in Korea.

Clinical Trial Description

Backgrounds:

The success rate of Helicobacter pylori eradication in Korea is not sufficient in recent days. The main cause of eradication failure is known as antimicrobial resistance and previous studies showed that resistant rates were different according to the regions in Korea. However, until now, there are not enough studies about the nationwide results for antimicrobial resistance and previous reports used various methods for the resistant test.

Theories and Plans:

The nationwide resistant registry of Helicobacter pylori using standardized single method, agar dilution test, can be useful for the development of new eradication methods to make eradication rate higher. Moreover, the higher rate of Helicobacter pylori eradication can reduce the chance of gastric cancer and also can reduce the medical expenses. ;

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Disease Susceptibility
• Gastric Cancer
• Gastritis
• Helicobacter Infections
• Helicobacter Pylori Infection
• Lymphoma
• Peptic Ulcer
• Stomach Neoplasms

• NCT number: NCT02961296
• Study type: Observational [Patient Registry]
• Source: Asan Medical Center
• Contact: Hwoon-Yong Jung, M.D., Ph.D.
• Email: hyjung@amc.seoul.kr
• Status: Not yet recruiting
• Phase: N/A
• Start date: October 2016
• Completion date: December 2018